ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Above 50 Day Moving Average – Time to Sell?

Shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $81.73 and traded as high as $83.21. ProShares Ultra Nasdaq Biotechnology shares last traded at $81.97, with a volume of 6,034 shares trading hands.

ProShares Ultra Nasdaq Biotechnology Stock Performance

The business’s fifty day moving average price is $81.73 and its 200-day moving average price is $81.64. The stock has a market cap of $76.23 million, a PE ratio of 20.68 and a beta of 1.25.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

Institutional investors have recently made changes to their positions in the stock. Franklin Resources Inc. purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 2nd quarter valued at about $32,000. Citadel Advisors LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 3rd quarter valued at about $307,000. Kaizen Financial Strategies purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 4th quarter valued at about $424,000. Finally, Palumbo Wealth Management LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 3rd quarter valued at about $766,000.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.